Free Trial

F M Investments LLC Purchases New Position in Quanterix Co. (NASDAQ:QTRX)

Quanterix logo with Medical background

F M Investments LLC purchased a new position in Quanterix Co. (NASDAQ:QTRX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 59,922 shares of the company's stock, valued at approximately $637,000. F M Investments LLC owned 0.16% of Quanterix at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Quanterix by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 2,217,225 shares of the company's stock worth $23,569,000 after purchasing an additional 19,386 shares during the period. William Blair Investment Management LLC bought a new position in shares of Quanterix in the fourth quarter valued at approximately $11,290,000. Easterly Investment Partners LLC grew its stake in Quanterix by 9.0% during the fourth quarter. Easterly Investment Partners LLC now owns 954,995 shares of the company's stock valued at $10,152,000 after acquiring an additional 78,862 shares in the last quarter. Geode Capital Management LLC increased its holdings in Quanterix by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 863,503 shares of the company's stock worth $9,181,000 after acquiring an additional 4,836 shares during the period. Finally, State Street Corp lifted its stake in Quanterix by 2.2% in the 3rd quarter. State Street Corp now owns 836,443 shares of the company's stock worth $10,840,000 after purchasing an additional 18,050 shares in the last quarter. 86.48% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently commented on QTRX. Scotiabank restated an "outperform" rating on shares of Quanterix in a research report on Tuesday, March 25th. Canaccord Genuity Group decreased their target price on Quanterix from $20.00 to $15.00 and set a "buy" rating on the stock in a research note on Tuesday, March 18th.

Read Our Latest Report on QTRX

Quanterix Trading Down 1.2 %

Shares of Quanterix stock traded down $0.06 on Thursday, hitting $5.10. 266,458 shares of the company traded hands, compared to its average volume of 538,098. Quanterix Co. has a 12-month low of $4.67 and a 12-month high of $19.18. The firm's 50-day simple moving average is $6.91 and its 200 day simple moving average is $9.88. The company has a market cap of $197.82 million, a P/E ratio of -4.83 and a beta of 1.35.

Quanterix (NASDAQ:QTRX - Get Free Report) last issued its quarterly earnings results on Monday, March 17th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The firm had revenue of $35.16 million for the quarter, compared to the consensus estimate of $34.93 million. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. Analysts predict that Quanterix Co. will post -0.98 earnings per share for the current year.

About Quanterix

(Free Report)

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.

Read More

Institutional Ownership by Quarter for Quanterix (NASDAQ:QTRX)

Should You Invest $1,000 in Quanterix Right Now?

Before you consider Quanterix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quanterix wasn't on the list.

While Quanterix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines